Statins Key Intermediate Synthesis via Mild Ketal Exchange
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing the key intermediate 2-[(4R,6S)-6-[(benzo[d]thiazol-2-ylthio)methyl]-2,2-dimethyl-1,3-dioxan-4-yl] acetate for statins are complex, costly, and energy-intensive due to the need for low-temperature reactions, making them unsuitable for industrial applications.
Innovation Solution
A method involving nucleophilic substitution of a halomethyl compound with a thiol reagent in an organic solvent, followed by a ketal exchange reaction with a carbonyl compound in the presence of an organic acid, to produce the target compound under mild conditions, allowing for a one-pot process with high yield and simplicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If low-temperature reactions (−78° C.) are used to prepare the chiral intermediate, then the stereochemical purity is improved, but the energy consumption increases and the operation complexity increases
Solution Approach 1:
The patent changes the temperature parameter from low-temperature (−78° C.) to room temperature or mild heating conditions, thereby reducing energy consumption while maintaining acceptable stereochemical purity through the specific reaction pathway design
Solution Approach 2:
The patent performs the ketal exchange reaction before the nucleophilic substitution reaction, establishing the chiral structure earlier in the synthesis pathway, which eliminates the need for subsequent low-temperature operations to preserve stereochemistry
2Manufacturing precision
If low-temperature reactions (−78° C.) are used to prepare the chiral intermediate, then the stereochemical purity is improved, but the device complexity increases
Solution Approach 1:
The patent performs the ketal exchange reaction before the nucleophilic substitution reaction, establishing the chiral structure earlier in the synthesis pathway, which eliminates the need for subsequent low-temperature operations to preserve stereochemistry
Solution Approach 2:
The patent combines multiple reaction steps into a simplified sequence where the ketal exchange is performed first, followed by nucleophilic substitution at ambient or mild conditions, reducing the need for complex temperature control equipment and procedures
3Reliability
If the traditional two-step method is used, then the synthesis pathway is established, but the production time increases
Solution Approach 1:
The patent performs the ketal exchange reaction before the nucleophilic substitution reaction, establishing the chiral structure earlier in the synthesis pathway, which allows for more efficient process integration and reduced overall production time
Solution Approach 2:
The patent designs the reaction sequence to allow continuous processing where the product of the first reaction directly feeds into the second reaction without requiring isolation or intermediate purification steps, thereby reducing production time
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high yield (>90%) and simplicity, eliminating the need for extreme cold conditions, reducing costs, and simplifying operations, making it suitable for industrial applications.
Implementation Method 1
subjecting a halomethyl compound and a thiol reagent to nucleophilic substitution in an organic solvent to synthesize a thioether
Implementation Method 2
subjecting the thioether and a carbonyl compound to ketal exchange reaction in the presence of an organic acid to synthesize the 2-[(4R,6S)-6-[(benzo[d]thiazol-2-ylthio)methyl]-2,2-disubstituted-1,3-dioxan-4-yl] acetate (I)
Data Source
AI summary
Disclosed herein relates to organic synthesis, and more particularly to a method for preparing a key intermediate for the synthesis of statins. The key intermediate is 2-[(4R,6S)-6-[(benzo[d]thiazol-2-ylthio)methyl]-2,2-disubstituted-1,3-dioxan-4-yl] acetate of formula (I):where R1 is a C1-C8 alkyl group, a C3-C8 cycloalkyl group, a monosubstituted or polysubstituted aryl group, or monosubstituted or polysubstituted aralkyl group; R2 is hydrogen, or monosubstituted or polysubstituted C1-C3 alkyl group, or halogen; and R3 and R4 are each independently a C1-C5 alkyl group, a C3-C7 cycloalkyl group, a C3-C7 cycloalkenyl group, a C1-C3 alkoxy group, a C6-C10 aryl group, or C7-C12 aralkyl group. In the method, a halomethyl compound and a thiol reagent are subjected to nucleophilic substitution in an organic solvent to synthesize a thioether, which then undergoes ketal exchange reaction with a carbonyl compound (V) in the presence of an organic acid to obtain a target product.